PKM and breast cancer: Additionally, a combination of PKM2 inhibitors (gliotoxin and shikonin) was found to sensitize high-density MDA-MB-231 breast cancer cells to the cytotoxic effect of vincristine, which was substantiated by increased apoptosis of the breast cancer cells [167].